PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
116.75%
Net income growth above 1.5x CRON.TO's 37.71%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-4.73%
Negative yoy D&A while CRON.TO is 49.68%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
154.86%
Deferred tax of 154.86% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
233.73%
SBC growth while CRON.TO is negative at -29.03%. John Neff would see competitor possibly controlling share issuance more tightly.
71.68%
Well above CRON.TO's 122.25% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
227.71%
AR growth well above CRON.TO's 256.12%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-130.74%
Both reduce yoy inventory, with CRON.TO at -10.63%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
100.00%
Lower AP growth vs. CRON.TO's 470.22%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-188.33%
Negative yoy usage while CRON.TO is 111.41%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-83.66%
Both negative yoy, with CRON.TO at -443.33%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
81.64%
Operating cash flow growth above 1.5x CRON.TO's 49.04%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
53.79%
Some CapEx rise while CRON.TO is negative at -159.54%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-92.62%
Both yoy lines negative, with CRON.TO at -4975.44%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
19.12%
We have mild expansions while CRON.TO is negative at -40521.00%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-83.52%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.